CN1178680C - Medicine of treating dermatosis for external use - Google Patents
Medicine of treating dermatosis for external use Download PDFInfo
- Publication number
- CN1178680C CN1178680C CNB011240687A CN01124068A CN1178680C CN 1178680 C CN1178680 C CN 1178680C CN B011240687 A CNB011240687 A CN B011240687A CN 01124068 A CN01124068 A CN 01124068A CN 1178680 C CN1178680 C CN 1178680C
- Authority
- CN
- China
- Prior art keywords
- medicine
- treatment
- external use
- dermatosis
- weight portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to an external application medicine for treating dermatosis, which is used for treating various kinds of suppurative dermatosis, sycosis, burn, external hemorrhoid and the antisepsis of the trauma surface of skin. The raw materials of the medicine is mainly prepared from 15 to 40 wt% of coptis, 15 to 35 wt% of pearl, 15 to 30 wt% of borneol and 400 to 580 wt% of vaseline. The medicine has evident curative effect on the treatment of suppurative dermatosis, effective rate is 100%, cure rate is 95%, and the medicine has no toxic or side effect and no scar remained after cure, and is an ideal medicine for external application for the treatment of various suppurative dermatoses.
Description
Described field
The present invention relates to the dermopathic medicine for external use of a kind of treatment, can be used for treating all kinds of suppurative dermatosis, tinea barbae, burn, external hemorrhoid, also can be used for the anticorrosion of skin trauma face.
Background technology
The dermopathic medicine for external use of treatment mainly contains erythromycin ointment, Piyanping ointment etc. at present, and aspect the treatment suppurative dermatosis, the curative effect of these medicines can't be satisfactory.
Recent years, relevant document also discloses a large amount of new external use medicine for treating dermatosis.Name is called " Chinese medicine preparation of treatment dermatosis and abscess carbuncle ", application number is the Chinese patent application of " 97122083 ", provides a kind of by 15 kinds of external use medicine for treating dermatosis that Chinese herbal medicine is formed such as Folium Artemisiae Argyi, Radix Polygoni Multiflori, Rhizoma Coptidis; Name is called " the dermopathic ointment of a kind of treatment ", application number provides a kind of external use medicine for treating dermatosis of being made up of raw materials such as 17-hydroxy-11-dehydrocorticosterone on vaseline, Borneolum Syntheticum, sulfur, Herba Senecionis Scandentis, papermulberry oil, Rhizoma Smilacis Glabrae, the kidney for the patent application of " 98113579 "; Name is called " a kind of medicine for the treatment of the various skin disease and preparation method thereof ", application number provides a kind of dermatosis treating medicine of mainly being made up of Borneolum Syntheticum, Camphora, Resina garciniae, Sanguis Draxonis, Radix Glycyrrhizae etc. for the patent application of " 99124402 ".
Summary of the invention
The purpose of this invention is to provide the dermopathic medicine for external use of a kind of new treatment, this medicine for external use has better therapeutic to the treatment of suppurative dermatosis.
The purpose of invention realizes by following mode.
Treat dermopathic medicine for external use, its raw material composition mainly is: Rhizoma Coptidis 15-40 weight portion, Margarita 15-35 weight portion, Borneolum Syntheticum 15-30 weight portion, vaseline 400-580 weight portion.
Rhizoma Coptidis, chemical constituent mainly are little folds in a garment alkali, and content is 5-8%, nature and flavor hardship, cold has wide spectrum and stronger antibacterial action, and staphylococcus aureus, Streptococcus hemolyticus, anaerobe are all had the good restraining effect, function with heat clearing and damp drying, eliminating fire and detoxication, but oral administration and external.Margarita, contain a large amount of calcium carbonate, generally more than 90%, contain inorganic elements Ca, Mn, Sr, Cu, Fe and a certain amount of organic object angle glutelin and a large amount of aminoacid, its nature and flavor are sweet, one-tenth, cold, press down the effect of aching, bring down a fever, calming the nerves arresting convulsion, external removing toxic substances and promoting granulation but have, skin ulcer is itched not hold back has curative effect, aspect infection, the promotion wound healing certain effect is being arranged.Borneolum Syntheticum, its chemical constituent mainly is Borneolum Syntheticum, isoborneol and Camphora, nature and flavor are arduous to be slightly cold, can promote the neurogliocyte growth, staphylococcus aureus, beta hemolytic streptococcus, viridans streptococci all there is the good restraining effect, but the external heat clearing away relieves the pain, anticorrosion antipruritic, has the function of anti-inflammation detumescence.Vaseline has hemostasis and moistening skin effect.In above-mentioned four kinds of raw materials, vaseline is substrate.
That Rhizoma Coptidis, Margarita and three kinds of raw materials of Borneolum Syntheticum all have is antibiotic, infection, relieve the pain, antipruritic, stop blooding, bring down a fever, the effect of healing of wound, for the curative effect of the dermopathic medicine for external use of treatment of the present invention provides assurance.This medicine for external use prescription and dose compatibility are reasonable, and higher novelty is arranged.Clinical trial shows, this medicine for external use has that heat-clearing and toxic substances removing, repellent antipruritic, putrefaction-removing granulation-promoting, hemostasis relieve the pain, antiallergic, anti-infective function; The protection wound surface is arranged, promote the granulation growth, recover epithelium and antiinflammatory astriction; The effect of antisepsis and sterilization, softening crust is arranged, and slough is discharged in the liquefaction of energy non-invasi, skin is repaired in physiological regeneration; Evident in efficacy aspect the treatment suppurative dermatosis; Long shelf-life, treatment cycle is short, and has no side effect, and is the desirable medicine for external use of all kinds of suppurative dermatosis of treatment, and is also better in aspect curative effects such as treatment tinea barbae, burn, external hemorrhoids.
Be coated with outward or external application with medicine for external use of the present invention, suppurative dermatosis is carried out test of cure, compare with erythromycin ointment, random packet is observed 200 examples, wherein use test group 100 examples of medicine for external use of the present invention, matched group 100 examples, smear 1-2 every day, 3-5 days is 1 course of treatment, judges curative effect after 1-2 the course of treatment.Result of the test shows: test group effective percentage 100%, cure rate 95%; Matched group effective percentage 80%, cure rate 5%; Learn by statistics and handle, two groups of curative effects have utmost point significant difference (P＜0.01), and the test group curative effect is better than matched group, and has no side effect, the back preventing from scar of healing, and therapeutic effect is satisfactory.
The specific embodiment
Provide four groups of concrete raw materials for the treatment of dermopathic medicine for external use to form mode below:
1, Rhizoma Coptidis 25 weight portions, Margarita 25 weight portions, Borneolum Syntheticum 20 weight portions, vaseline 500 weight portions.
2, Rhizoma Coptidis 15 weight portions, Margarita 35 weight portions, Borneolum Syntheticum 20 weight portions, vaseline 500 weight portions.
3, Rhizoma Coptidis 25 weight portions, Margarita 15 weight portions, Borneolum Syntheticum 30 weight portions, vaseline 500 weight portions.
4, Rhizoma Coptidis 40 weight portions, Margarita 20 weight portions, Borneolum Syntheticum 15 weight portions, vaseline 500 weight portions.
Preparation method can adopt routine fashion:
1, grind and method: Rhizoma Coptidis behind the dry disinfection and Borneolum Syntheticum are ground into fine powder, and Margarita powder is crossed thin sieve of 100-120 order, drops in the container, earlier with a small amount of vaseline mixed grinding, slowly adds remaining vaseline again after treating evenly, grinds to be in harmonious proportion evenly to get final product.
2, heavy dose of method for making: general heavy dose of production all adopts electronic sterilizing, blender to make.
The character of medicine for external use: faint yellow or yellow ointment.
Claims (2)
1, the dermopathic medicine for external use of a kind of treatment is characterized in that being made up of following raw material: Rhizoma Coptidis 15-40 weight portion, Margarita 15-35 weight portion, Borneolum Syntheticum 15-30 weight portion, vaseline 400-580 weight portion.
2, the dermopathic medicine for external use of a kind of treatment according to claim 1 is characterized in that being made up of following raw material: Rhizoma Coptidis 25 weight portions, Margarita 25 weight portions, Borneolum Syntheticum 20 weight portions, vaseline 500 weight portions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011240687A CN1178680C (en) | 2001-08-13 | 2001-08-13 | Medicine of treating dermatosis for external use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011240687A CN1178680C (en) | 2001-08-13 | 2001-08-13 | Medicine of treating dermatosis for external use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1401336A CN1401336A (en) | 2003-03-12 |
| CN1178680C true CN1178680C (en) | 2004-12-08 |
Family
ID=4665475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011240687A Expired - Fee Related CN1178680C (en) | 2001-08-13 | 2001-08-13 | Medicine of treating dermatosis for external use |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1178680C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106860518A (en) * | 2017-03-20 | 2017-06-20 | 李衍波 | Treat medicine of empyrosis and preparation method thereof |
| CN111840436A (en) * | 2019-04-24 | 2020-10-30 | 程浩 | Traditional Chinese medicine ointment for treating animal trauma and preparation method thereof |
-
2001
- 2001-08-13 CN CNB011240687A patent/CN1178680C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1401336A (en) | 2003-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1053116C (en) | Cosmetical face film with Chinese medicines | |
| CN101129507A (en) | External use medicine for treating dermatosis | |
| CN101229322A (en) | External medicine for treating surgery and dermatology department diseases and preparing method thereof | |
| CN101244185A (en) | Chinese medicinal herb composition for treating skin disease and cloth containing the combination | |
| CN1178680C (en) | Medicine of treating dermatosis for external use | |
| CN1192896A (en) | Recipe of tooth-powder of Chinese medicinal herbs and production technology thereof | |
| CN104940627A (en) | Traditional Chinese medicine composition for promoting wound healing, and preparation method of traditional Chinese medicine composition | |
| CN101797338A (en) | Traditional Chinese medicine mask powder with acne-removing inflammation-diminishing function and preparation method thereof | |
| CN116549612A (en) | Antibacterial composition containing plant stem cell factor and preparation method thereof | |
| CN1251746C (en) | Ointment for curing burn | |
| CN1052645C (en) | Traditional Chinese medicine "Zhenhuang" powder and its production method | |
| CN102048880A (en) | Externally applied ointment for adjuvant therapy of pharyngitis and canker sore and preparation method thereof | |
| CN1476884A (en) | Inflammation-relieving plaster and its production method | |
| CN100335086C (en) | Medication for treating impetigo | |
| CN1562140A (en) | Chinese-western combined medicine for treating burn and scald and other external wound | |
| CN1061861C (en) | Composite natural synergic essence and preparing process and use thereof | |
| CN1679744A (en) | Medicine preparation for treating chronic pharyngitis | |
| CN1038477C (en) | Oral liquor for treatment of psoriasis | |
| CN1048657A (en) | The compound method of treatment psoriasis and tinea cruris medicament | |
| CN1221619A (en) | Apocatastasis powder | |
| CN111617142A (en) | Chinese patent medicine for treating burns and scalds and preparation method thereof | |
| CN110882270B (en) | Pharmaceutical composition containing silicon-based regenerative medical material and preparation method thereof | |
| CN1354005A (en) | Medicine for curing tinea manuum and tinea pedis and preparing method thereof | |
| CN1089599C (en) | Traditional Chinese medicinal preparation for treating pulmonary tuberculosis | |
| CN1163245C (en) | Toxin-absorbing drying medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |